For instance, they should be exhibiting a progression of sensory ataxia and/or cardiomyopathy due to reduced frataxin protein level, ideally as a result of GAA expansions in the first intron of the FXN gene (Perdomini et al., 2013). This evidence concerns the gene FXN and sensory ataxia.